Drug-drug Interactions Between DWC202211 and DWC202212 in Healthy Subjects

NCT05699070 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug-drug Interaction

Interventions

DRUG: DWC202211 100mg
DRUG: DWC202212 5mg
DRUG: DWC202211 100mg + DWC202212 5mg

Sponsor

Daewoong Pharmaceutical Co. LTD.